BRAINP.CO Stock - Brain+ A/S
Unlock GoAI Insights for BRAINP.CO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $7.86M | $2.35M | $2.64M | $3.99M | $6.01M |
| Gross Profit | $7.86M | $2.35M | $3.23M | $3.99M | $6.01M |
| Gross Margin | 100.0% | 100.0% | 122.3% | 100.0% | 100.0% |
| Operating Income | $-11,660,536 | $-17,506,830 | $-11,084,452 | $-7,266,873 | $-1,410,000 |
| Net Income | $-12,045,412 | $-19,124,815 | $-9,679,595 | $-7,079,752 | $-1,279,000 |
| Net Margin | -153.3% | -813.0% | -366.2% | -177.3% | -21.3% |
| EPS | $-0.09 | $-0.49 | $-0.52 | $-0.89 | $-8.90 |
Brain+ A/S develops digital therapeutics for Alzheimer's and dementia. The company develops cognitive stimulation therapy (CST), a therapy that treats the main symptoms of dementia; Computerized Cognitive Training, a cognitive training method for patients with mild cognitive impairment; and Starry Night, memory test for early detection and monitoring of Alzheimer's. In addition, it develops an interface for clinicians to track and trace the patient's treatment progress. The company was incorporated in 2012 and is based in Copenhagen, Denmark. Brain+ A/S was formerly a subsidiary of Brain+ Holding ApS.
Visit WebsiteEarnings History & Surprises
BRAINP.COEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 22, 2025 | — | $-0.02 | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 22, 2024 | — | $-0.09 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.21 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.30 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.28 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.22 | — | — |